Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CGN-005 is an investigational bowel cleansing agent currently in the preclinical stage of development by CitraGen Pharmaceuticals. It is being developed for use in gastrointestinal preparation, typically required before procedures such as colonoscopies or colorectal surgeries to ensure clear visualization of the intestinal mucosa. While the specific chemical composition and precise mechanism of action—such as whether it acts as an osmotic agent, a stimulant laxative, or a combination formulation—have not been publicly disclosed, the asset is a key part of CitraGen's specialty pharmaceutical pipeline focused on gastrointestinal health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CGN-005.